These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 15690309)
1. Fibrinogen and other coronary risk factors. Von Eyben FE; Mouritsen EA; Holm J; Montvilas P; Dimcevski G; Rasmussen IH; Kristensen LL; Suciu G; Von Eyben R Metabolism; 2005 Feb; 54(2):165-70. PubMed ID: 15690309 [TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction. Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002 [TBL] [Abstract][Full Text] [Related]
3. Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study. Assmann G; Cullen P; Heinrich J; Schulte H Isr J Med Sci; 1996 Jun; 32(6):364-70. PubMed ID: 8682642 [TBL] [Abstract][Full Text] [Related]
4. Inter-relationships of plasma fibrinogen, low-density lipoprotein cholesterol, cigarette smoking and the prevalence of cardiovascular disease. Fowkes FG; Lee AJ; Lowe GD; Riemersma RA; Housley E J Cardiovasc Risk; 1996 Jun; 3(3):307-11. PubMed ID: 8863104 [TBL] [Abstract][Full Text] [Related]
5. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction. Farwell WR; Sesso HD; Buring JE; Gaziano JM Am J Cardiol; 2005 Oct; 96(8):1129-34. PubMed ID: 16214451 [TBL] [Abstract][Full Text] [Related]
6. Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations. Wang Z; Rowley K; Best J; McDermott R; Taylor M; O'Dea K Metabolism; 2007 May; 56(5):629-35. PubMed ID: 17445537 [TBL] [Abstract][Full Text] [Related]
7. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Hadaegh F; Harati H; Ghanbarian A; Azizi F Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147 [TBL] [Abstract][Full Text] [Related]
8. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction. Vayá A; Falcó C; Réganon E; Vila V; Martínez-Sales V; Corella D; Contreras MT; Aznar J Thromb Haemost; 2004 Feb; 91(2):354-9. PubMed ID: 14961164 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice. Kim SH; Chunawala L; Linde R; Reaven GM J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178 [TBL] [Abstract][Full Text] [Related]
10. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. Erkkilä AT; Lindi V; Lehto S; Laakso M; Uusitupa MI Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038 [TBL] [Abstract][Full Text] [Related]
11. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227 [TBL] [Abstract][Full Text] [Related]
12. Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles. Yoshida T; Yajima K; Hibino T; Kato K; Matsuo H; Segawa T; Watanabe S; Oguri M; Yokoi K; Nozawa Y; Kimura G; Yamada Y Int J Mol Med; 2007 Oct; 20(4):581-90. PubMed ID: 17786291 [TBL] [Abstract][Full Text] [Related]